Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nanotechnology, Science and Applications | journal | 2.004 Q1 | 35 | 4 | 22 | 261 | 292 | 22 | 7.00 | 65.25 | 42.11 | |
2 | Biomarker Insights | journal | 1.253 Q1 | 40 | 16 | 73 | 836 | 288 | 73 | 3.84 | 52.25 | 38.71 | |
3 | International Journal of Nanomedicine | journal | 1.061 Q1 | 179 | 686 | 1714 | 36656 | 9268 | 1709 | 5.43 | 53.43 | 42.35 | |
4 | Core Evidence (discontinued) | journal | 1.054 Q1 | 29 | 0 | 10 | 0 | 53 | 10 | 5.60 | 0.00 | 0.00 | |
5 | Pharmacogenomics and Personalized Medicine | journal | 0.967 Q1 | 37 | 34 | 69 | 2240 | 271 | 66 | 3.76 | 65.88 | 42.07 | |
6 | Infection and Drug Resistance | journal | 0.966 Q1 | 65 | 390 | 350 | 15234 | 1171 | 341 | 3.31 | 39.06 | 44.71 | |
7 | Drug Design, Development and Therapy | journal | 0.880 Q1 | 94 | 379 | 1064 | 15240 | 3576 | 1044 | 3.44 | 40.21 | 41.69 | |
8 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.862 Q2 | 64 | 254 | 187 | 11039 | 612 | 181 | 3.04 | 43.46 | 43.93 | |
9 | Patient Preference and Adherence | journal | 0.794 Q1 | 67 | 208 | 727 | 7623 | 1738 | 716 | 2.18 | 36.65 | 51.53 | |
10 | Drug, Healthcare and Patient Safety | journal | 0.473 Q3 | 30 | 15 | 35 | 565 | 72 | 35 | 1.91 | 37.67 | 40.32 | |
11 | Fluoride - Quarterly Reports | journal | 0.288 Q4 | 51 | 52 | 131 | 1740 | 135 | 117 | 0.88 | 33.46 | 45.41 | |
12 | Open Access Journal of Clinical Trials | journal | 0.219 Q3 | 15 | 6 | 19 | 226 | 14 | 19 | 0.85 | 37.67 | 41.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®